Journal Articles — Victor M. Rivera, M.D., FAAN

Dr. Victor M. Rivera has authored and co-authored 115 journal articles. They are listed here in reverse chronological order and grouped by published year. Click on the Expand plus symbol or Collapse minus symbol symbol to expand/collapse the list of journal publications by year, respectively.

Click on the PubMed link for details of that publication.

The cite count designates the number of times the publication has been cited by other papers indexed in Scopus. To access cite count information powered by Scopus, you must have a valid Texas Medical Center Resource Access Account. Need to register for access or forget password? Click here.

Sort By:    Year Published    Cite Count

2022

Collapse All | Expand All

Journal Articles Published in 2022 (n = 1)

Cite Count

PubMed

Reference

0     

Gracia F, Ramírez D, Parajeles-Vindas A, Díaz A, Díaz de la Fé A, Sánchez NER, et al. Neuromyelitis optica spectrum disorder in Central America and the Caribbean: A multinational clinical characterization study. Neurol Int. 2022;14(1):284-93. DOI: 10.3390/neurolint14010023.

2021

Collapse All | Expand All

Journal Articles Published in 2021 (n = 5)

Cite Count

PubMed

Reference

0     

Amezcua L, Rivera VM, Vazquez TC, Baezconde-Garbanati L, Langer-Gould A. Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: A review. JAMA Neurol. 2021;78(12):1515-24. PMID: 34605866.

0     

Cristiano E, Abad P, Becker J, Carra A, Correale J, Flores J, et al. Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation. J Neurol Sci. 2021;429:118072. PMID: 34509134.

0     

Rivera VM, Hamuy F, Rivas V, Gracia F, Rojas JI, Bichuetti DB, et al. Status of the neuromyelitis optica spectrum disorder in Latin America. Mult Scler Relat Disord. 2021;53:103083. DOI: https://doi.org/10.1016/j.msard.2021.103083.

0     

Rivera VM. Editorial of special issue "Multiple sclerosis: Diagnosis and treatment II". Biomedicines. 2021;9(11):. PMID: 34829833.

0     

Rojas JI, Carnero Contentti E, Abad P, Aguayo A, Alonso R, Bauer J, et al. Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAM. Mult Scler Relat Disord. 2021;53:103038. PMID: 34090128.

2020

Collapse All | Expand All

Journal Articles Published in 2020 (n = 2)

Cite Count

PubMed

Reference

0     

Fisher KS, Cuascut FX, Rivera VM, Hutton GJ. Current advances in pediatric onset multiple sclerosis. Biomedicines. 2020;8(4):. PMID: 32231060.

0     

Rivera VM, Gracia F, Diaz A. Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia. Neurologia. 2020;35(9):705-6. PMID: 32893070.

<2019

Collapse All | Expand All

Journal Articles Published in <2019 (n = 107)

Cite Count

PubMed

Reference

1

Rivera VM. Biosimilar drugs for multiple sclerosis: An unmet international need or a regulatory risk? Neurol Ther. 2019;8(2):177-84. PMID: 31313222.

0     

Rivera VM. Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries. Eur J Neurol. 2018;25(4):612-3. PMID: 29341368.

3

Rivera VM. Multiple sclerosis: a global concern with multiple challenges in an era of advanced therapeutic complex molecules and biological medicines. Biomedicines. 2018;6(4):. PMID: 30513578.

0     

Rivera VM. Multiple sclerosis: depression and disability are globally shared issues of concern. Neurol Neuroimmunol Neuroinflamm. 2018;5(4):12. DOI: 10.20517/2347-8659.2018.16.

0     

Rivera VM, Macias MA. Access and barriers to MS care in Latin America. Mult Scler J Exp Transl Clin. 2017;3(1):2055217317700668. DOI: doi:10.1177/2055217317700668.

0     

Rivera VM. Medicinal cannabis: Cultural, societal and regulatory challenges in the Americas. Ann Forensic Res Anal. 2017;4(1):1038.

7

Rivera VM. Multiple Sclerosis in Latin Americans: Genetic Aspects. Curr Neurol Neurosci Rep. 2017;17(8):57. PMID: 28639238.

0     

Rivera-Olmos VM, Parra-Bernal MC. [Cannabis: Effects in the central nervous system. Therapeutic, societal and legal consequences]. Rev Med Inst Mex Seguro Soc. 2016;54(5):626-34. PMID: 27428345.

11

Rivera VM, Medina MT, Duron RM, Macias MA. Multiple sclerosis care in Latin America. Neurology. 2014;82(18):1660-1. PMID: 24799516.

4

Macias-Islas MA, Soria-Cedillo IF, Velazquez-Quintana M, Rivera VM, Baca-Muro VI, Lemus-Carmona EA, et al. Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis. Acta Neurol Belg. 2013;113(4):415-20. PMID: 23670405.

25

Rivera VM, Jeffery DR, Weinstock-Guttman B, Bock D, Dangond F. Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study. BMC Neurol. 2013;13:80. PMID: 23841877.

6

Abad P, Nogales-Gaete J, Rivera V, Cristiano E, Hamuy F, Oehninger C, et al. [LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants]. Rev Neurol. 2012;55(12):737-48. PMID: 23233142.

0     

Avila-Ornelas J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ, et al. The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis. Int J MS Care. 2011;13(2):91-3. PMID: 24453710.

4

Rivera VM. Tovaxin for multiple sclerosis. Expert Opin Biol Ther. 2011;11(7):961-7. PMID: 21563876.

11

Stosic M, De Jesus P, McCarthy J, Hutton G, Rivera V. Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology. 2011;77(5):505-7. PMID: 21775738.

35

Uitdehaag B, Constantinescu C, Cornelisse P, Jeffery D, Kappos L, Li D, et al. Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study. Ther Adv Neurol Disord. 2011;4(1):3-14. PMID: 21339904.

19

Cohen BA, Rivera VM. PRISMS: The story of a pivotal clinical trial series in multiple sclerosis. Curr Med Res Opin. 2010;26(4):827-38. PMID: 20121658.

1

Rivera VM. The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology. 2010;74(10):864. PMID: 20211915.

10

Rivera VM. Multiple sclerosis in Latin America: Reality and challenge. Neuroepidemiology. 2009;32(4):294-5. PMID: 19246934.

0     

Cristiano E, Arcega R, Correale J, Gabbay AA, Lander-Delgado R, Macias-Islas MA, et al. [Recommendations for optimising the treatment of multiple sclerosis in Latin America]. Rev Neurol. 2007;44(8):494-8. PMID: 17455164.

9

Ordonez L, Skromne E, Ontaneda D, Rivera VM. Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome. Clin Neurol Neurosurg. 2007;109(1):102-5. PMID: 16624483.

0     

Rivera-Olmos VM, Avila MC. [Multiple sclerosis in Latin America. Are McDonald's criteria really applicable?]. Rev Mex Neuroci. 2007;8(1):49-56.

0     

 

Suarez GA, Hutton GJ, Rivera VM. Optic neuritis: Relation with multiple sclerosis. Acta Neurol Colomb. 2007;23:141-6.

0     

 

Suarez GA, Lotze TE, Hutton GJ, Rivera VM. Multiple sclerosis in the pediatric population. Acta Neurol Colomb. 2007;23:134-40.

87

Butzkueven H, Chapman J, Cristiano E, Grand'Maison F, Hoffmann M, Izquierdo G, et al. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler. 2006;12(6):769-74. PMID: 17263005.

0     

Carra A, Rivera-Olmos V, Arcega R, Gabbai A, Haussen SR, Luetic G, et al. [The treatment of multiple sclerosis in Latin America: Current practice and optimal standards. The findings of a survey among neurologists at an interactive workshop]. Rev Neurol. 2006;42(7):399-407. PMID: 16602056.

1

Skromne E, Rivera VM, Ontaneda D, Ordonez L. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology. 2006;66(11):1787-8; author reply 1787-8. PMID: 16769975.

2

Rivera VM. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2005;64(12):2163. PMID: 15985607.

9

Rivera VM. Modafinil for the treatment of diminished responsiveness in a patient recovering from brain surgery. Brain Inj. 2005;19(9):725-7. PMID: 16195186.

1

Rivera VM. The terms Latino and Anglo and tendency to early Alzheimer disease. Arch Neurol. 2005;62(11):1787; author reply 1787-8. PMID: 16286562.

0     

Rivera-Olmos VM, Lozano JA. [Cogan's syndrome: Neurological manifestations. Case report and review of literature]. Rev Mex Neuroci. 2005;6(1):97-101.

50

Cohen BA, Khan O, Jeffery DR, Bashir K, Rizvi SA, Fox EJ, et al. Identifying and treating patients with suboptimal responses. Neurology. 2004;63(12 Suppl 6):S33-40. PMID: 15623669.

58

Hong J, Zang YC, Hutton G, Rivera VM, Zhang JZ. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. J Neuroimmunol. 2004;152(1-2):126-39. PMID: 15223245.

15

Hong J, Zang YC, Li S, Rivera VM, Zhang JZ. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes. Eur J Immunol. 2004;34(3):870-81. PMID: 14991617.

0     

 

Rivera VM. Esclerosis multiple: evidencias, genericos y similares. Rev Mex Neuroci. 2004;5(4):286-7.

0     

Rivera-Olmos VM, Hutton GJ, Breitbach WT. Discrepancia entre clinica e imagen: Esclerosis multiple en fase intermedia. Presentacion de un caso y revision del tema [Discrepancy between clinics and image techniques: Intermediate phase of multiple sclerosis. A case report and review of the literature]. Rev Mex Neuroci. 2004;5(2):158-62.

98

Zang YC, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT, et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol. 2004;172(8):5120-7. PMID: 15067096.

22

Zang YC, Skinner SM, Robinson RR, Li S, Rivera VM, Hutton GJ, et al. Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis. Mult Scler. 2004;10(5):499-506. PMID: 15471364.

161

Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M, et al. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;61(5):602-11. PMID: 12963748.

38

Frohman TC, Frohman EM, O'Suilleabhain P, Salter A, Dewey RB, Jr, et al. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology. 2003;61(6):848-50. PMID: 14504338.

0     

Rivera VM. [Deciding on treatment in multiple sclerosis]. Rev Neurol. 2003;36(1):80-5. PMID: 12577220.

149

Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol. 2003;53(2):189-97. PMID: 12557285.

0     

Velazquez-Quintana M, Macias-Islas MA, Rivera-Olmos V, Lozano-Zarate J. [Multiple sclerosis in Mexico: A multicentre study]. Rev Neurol. 2003;36(11):1019-22. PMID: 12808495.

28

Zang Y, Hong J, Robinson R, Li S, Rivera VM, Zhang JZ. Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis. J Neuroimmunol. 2003;137(1-2):144-53. PMID: 12667659.

21

Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells. Int Immunol. 2003;15(9):1073-80. PMID: 12917259.

33

Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler. 2002;8(3):237-42. PMID: 12120696.

0     

 

Rivera VM. II Congreso de LACTRIMS. Rev Neurol. 2002;35(12):1175-6.

9

Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis. Immunology. 2002;107(4):403-10. PMID: 12460184.

52

Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol. 2002;76(12):6147-54. PMID: 12021348.

64

Zang YC, Halder JB, Hong J, Rivera VM, Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol. 2002;124(1-2):106-14. PMID: 11958828.

49

Zhang JZ, Rivera VM, Tejada-Simon MV, Yang D, Hong J, Li S, et al. T cell vaccination in multiple sclerosis: Results of a preliminary study. J Neurol. 2002;249(2):212-8. PMID: 11985389.

73

Ciancio SJ, Mutchnik SE, Rivera VM, Boone TB. Urodynamic pattern changes in multiple sclerosis. Urology. 2001;57(2):239-45. PMID: 11182328.

7

Rivera VM, Cabrera JA. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology. 2001;57(5):937-8. PMID: 11552042.

0     

Rivera VM. [Neuroimaging in multiple sclerosis]. Rev Neurol. 2001;32(3):283-5. PMID: 11310287.

3

Rivera VM. [Pharmacologic treatment of multiple sclerosis]. Rev Neurol. 2001;32(3):285-8. PMID: 11310288.

0     

 

Rivera VM. La decada del cerebro. Neurociencia. 2001;2(13):131.

41

Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol. 2001;31(3):907-17. PMID: 11241296.

82

Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol. 2001;112(1-2):174-80. PMID: 11108946.

35

Hong J, Zang YC, Tejada-Simon MV, Li S, Rivera VM, Killian J, et al. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol. 2000;165(12):6858-64. PMID: 11120809.

0     

 

Rivera VM, Cabrera JA. La Esclerosis Multiple en Latino America. MEDICO Interamericano. 2000;19(10):458-65.

1

Rivera VM. [The treatment of multiple sclerosis with beta-interferon 1a]. Rev Neurol. 2000;31(5):470-1. PMID: 11027100.

0     

 

Rivera VM. Grupo de Estudio de EM (Mexico): Uso de Agentes Modificadores de la Enfermedad. Neurociencia. 2000;3:29-30.

0     

 

Rivera VM. Introduccion al Simposio Latino Americano. Rev Neurol. 2000;31(5):469.

29

Tejada-Simon MV, Zang YC, Yang D, Hong J, Li S, Singh RA, et al. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int Immunol. 2000;12(12):1641-50. PMID: 11099303.

59

Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol. 2000;164(8):4011-7. PMID: 10754292.

44

Zang YC, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, et al. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol. 2000;30(3):908-13. PMID: 10741408.

66

Zang YC, Samanta AK, Halder JB, Hong J, Tejada-Simon MV, Rivera VM, et al. Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. Brain. 2000;123 ( Pt 9):1874-82. PMID: 10960051.

48

Zang YC, Yang D, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology. 2000;55(3):397-404. PMID: 10932275.

54

Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA, et al. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol. 1999;163(6):3530-8. PMID: 10477628.

61

Kil K, Zang YC, Yang D, Markowski J, Fuoco GS, Vendetti GC, et al. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Neuroimmunol. 1999;98(2):201-7. PMID: 10430053.

98

Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, Killian JM, et al. Interferon beta induces T-helper 2 immune deviation in MS. Neurology. 1999;53(8):1692-7. PMID: 10563614.

28

Singh RA, Zang YC, Shrivastava A, Hong J, Wang GT, Li S, et al. Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70. J Immunol. 1999;163(12):6393-402. PMID: 10586029.

74

Zang YC, Kozovska MM, Hong J, Li S, Mann S, Killian JM, et al. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol. 1999;29(5):1692-700. PMID: 10359124.

22

Kozovska M, Zang YC, Aebischer I, Lnu S, Rivera VM, Crowe PD, et al. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: Structural requirements and clinical implications. Eur J Immunol. 1998;28(6):1894-901. PMID: 9645371.

14

Zang YC, Kozovska M, Aebischer I, Li S, Boehme S, Crowe P, et al. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int Immunol. 1998;10(7):991-8. PMID: 9701037.

63

Jerger J, Alford B, Lew H, Rivera V, Chmiel R. Dichotic listening, event-related potentials, and interhemispheric transfer in the elderly. Ear Hear. 1995;16(5):482-98. PMID: 8654903.

0     

Trujillo JR, Garcia-Ramos G, Novak IS, Rivera VM, Huerta E, Essex M. Neurologic manifestations of AIDS: A comparative study of two populations from Mexico and the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(1):23-9. PMID: 8548343.

118

Safi HJ, Bartoli S, Hess KR, Shenaq SS, Viets JR, Butt GR, et al. Neurologic deficit in patients at high risk with thoracoabdominal aortic aneurysms: The role of cerebral spinal fluid drainage and distal aortic perfusion. J Vasc Surg. 1994;20(3):434-44; discussion 442-3. PMID: 8084037.

255

Crawford ES, Svensson LG, Hess KR, Shenaq SS, Coselli JS, Safi HJ, et al. A prospective randomized study of cerebrospinal fluid drainage to prevent paraplegia after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg. 1991;13(1):36-45; discussion 45-6. PMID: 1987395.

85

Mawad ME, Rivera V, Crawford S, Ramirez A, Breitbach W. Spinal cord ischemia after resection of thoracoabdominal aortic aneurysms: MR findings in 24 patients. AJNR Am J Neuroradiol. 1990;11(5):987-91. PMID: 2121005.

44

Mawad ME, Rivera V, Crawford S, Ramirez A, Breitbach W. Spinal cord ischemia after resection of thoracoabdominal aortic aneurysms: MR findings in 24 patients. AJR Am J Roentgenol. 1990;155(6):1303-7. PMID: 2122684.

14

Rivera VM. Safety of intrathecal steroids in multiple sclerosis. Arch Neurol. 1989;46(7):718-9. PMID: 2535600.

0     

Olmos Garcia de Alba G, Gamboa Marrufo JD, Rengifo Ramos O, Calderon FE, Espinosa Tanguna R, Rivera Olmos VM, et al. Rett's syndrome with Lennox-Gastaut pattern. Clin Electroencephalogr. 1987;18(4):187-90. PMID: 3117441.

41

Jerger JF, Oliver TA, Chmiel RA, Rivera VM. Patterns of auditory abnormality in multiple sclerosis. Audiology. 1986;25(4-5):193-209. PMID: 3566629.

45

Rivera VM, Meyer JS, Hata T, Ishikawa Y, Imai A. Narcolepsy following cerebral hypoxic ischemia. Ann Neurol. 1986;19(5):505-8. PMID: 3717910.

3

Rivera VM. Multiple sclerosis. Is the mystery beginning to unfold? Postgrad Med. 1986;79(8):217-32. PMID: 3520524.

0     

Rivera VM. Stroke. A guide to differential diagnosis and prevention. Postgrad Med. 1985;77(4):81-8. PMID: 3975191.

51

Hannley M, Jerger JF, Rivera VM. Relationships among auditory brain stem responses, masking level differences and the acoustic reflex in multiple sclerosis. Audiology. 1983;22(1):20-33. PMID: 6830528.

5

Jerger J, Hannley M, Rivera V. Auditory brainstem response and the masking level difference. Ann N Y Acad Sci. 1982;388:466-70. PMID: 6953883.

5

Jerger J, Hannley M, Rivera V. Auditory brainstem response and the masking level difference. Ann N Y Acad Sci. 1982;388:466-70. PMID: 6953883.

6

Rivera VM. Intraspinal steroid therapy. Neurology. 1981;31(8):1060-1. PMID: 6894967.

15

Rivera VM, Grabois M, Deaton W, Breitbach W, Hines M. Modified snake venom in amyotrophic lateral sclerosis. Lack of clinical effectiveness. Arch Neurol. 1980;37(4):201-3. PMID: 7362484.

25

Jankovic J, Rivera VM. Hereditary myoclonus and progressive distal muscular atrophy. Ann Neurol. 1979;6(3):227-31. PMID: 534421.

5

Jankovic J, Rivera V. Hereditary myoclonus and progressive muscular atrophy: A new syndrome. Trans Am Neurol Assoc. 1978;103:116-8. PMID: 757033.

0     

 

Jankovic J, Rivera VM. Hereditary myoclonus and progressive spinal muscular atrophy: A new syndrome. Ann Neurol. 1978;4(2):170-1.

2

Perez FI, Hruska NA, Stell RL, Rivera VM. Computerized assessment of memory performance in dementia. Can J Neurol Sci. 1978;5(3):307-12. PMID: 359117.

0     

Rivera VM, Patten BM. Neuromyopathy in malignant hyperthermia. J Clin Psychiatry. 1978;39(1):67-71. PMID: 580262.

0     

Rivera VM. Acute hypokalemic myopathy in alcoholism. Arch Neurol. 1978;35(9):619. PMID: 687190.

0     

Guido EM, Rivera VM. Precordialgia as a manifestation of vertebrobasilar insufficiency. J Am Geriatr Soc. 1977;25(10):463-5. PMID: 903546.

0     

Rivera VM. Viruses and multiple sclerosis. Jama. 1977;238(12):1247. PMID: 578169.

0     

Rodriguez J, Rivera VM. Risk factors in stroke in a Mexican-American population (Houston). Neurol Neurocir Psiquiatr. 1977;18(2-3 Suppl):225-34. PMID: 616532.

1

Rivera VM. Letter: Symptomatic care of patients with amyotrophic lateral sclerosis. Jama. 1976;235(24):2584-5. PMID: 946858.

12

Perez FI, Gay JR, Taylor RL, Rivera VM. Patterns of memory performance in the neurologically impaired aged. Can J Neurol Sci. 1975;2(4):347-55. PMID: 1201525.

0     

Perez FI, Rivera VM, Meyer JS, Gay JR, Taylor RL, Mathew NT. Analysis of intellectual and cognitive performance in patients with multi-infarct dementia, vertebrobasilar insufficiency with dementia, and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1975;38(6):533-40. PMID: 1151420.

10

Rivera VM, Breitbach WB, Swanke L. Letter: Dantrolene in amyotrophic lateral sclerosis. Jama. 1975;233(8):863-4. PMID: 1173890.

9

Rivera VM, Keichian AH, Oliver RE. Persistent parkinsonism following neuroleptanalgesia. Anesthesiology. 1975;42(5):635-7. PMID: 1130732.

0     

Meyer JS, Bauer RB, Rivera-Olmos VM, Nolan DC, Lerner AM. Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol. 1970;23(5):438-50. PMID: 4319497.

See additional bibliometric measures (requires BCM login).